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Abstract
Background: Individuals with major psychotic and/or affective disorders are at increased risk for developing metabolic
syndrome due to lifestyle- and treatment-related factors. Numerous pharmacological and non-pharmacological
interventions have been tested in inpatient and outpatient mental health settings to decrease these risk factors. This
review focuses on primary care-based non-pharmacological (educational or behavioral) interventions to decrease
metabolic syndrome risk factors in adults with major psychotic and/or affective disorders.
Methods: The authors conducted database searches of PsychINFO, MEDLINE and the Cochrane Database of Systematic
Reviews, as well as manual searches and gray literature searches to identify included studies.
Results: The authors were unable to identify any studies meeting a priori inclusion criteria because there were no
primary care-based studies.
Conclusions: This review was unable to demonstrate effectiveness of educational interventions in primary care.
Interventions to decrease metabolic syndrome risk have been demonstrated to be effective in mental health and other
outpatient settings. The prevalence of mental illness in primary care settings warrants similar interventions to improve
health outcomes for this population.
Keywords: Metabolic syndrome, Serious mental illness, Primary care, Weight loss, Schizophrenia, Schizoaffective,
Bipolar, Major depressive disorder, Physical health intervention, Educational intervention, Behavioral intervention

Background
Comorbidity of mental illness and chronic physical illness

Individuals with major psychotic and/or affective disorders
(for example, schizophrenia, bipolar disorder or major
depressive disorder) experience higher rates of comorbid
physical health problems compared with the general population. Cardiovascular risk and metabolic risk are increased
in individuals with schizophrenia [1-3] and depression
[4,5]. Bipolar disorder has also been shown to be associated with metabolic syndrome [6,7]. Risk factors for cardiovascular disease and metabolic syndrome include: high
blood pressure, large waist circumference, high triglyceride
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levels, low HDL cholesterol level, and high fasting blood
sugar levels.
Causes of comorbidity in this population are thought to
include psychiatric medication and lifestyle factors, such
as diet and tobacco consumption. Atypical antipsychotic medication (AAP), commonly prescribed for patients
with bipolar disorder or schizophrenia, increases risk for
metabolic syndrome [8-10]. Individuals with major psychotic disorders, especially schizophrenic disorders, also consume tobacco at higher rates than the general population
[1,11-13], which partially explains the increased risk of
cardiovascular disease in this population. Bobes et al. [1]
found that tobacco users with major psychotic or affective/
mood disorders were more likely to consume daily alcohol
and caffeine and less likely to avoid salt and saturated
fats. Sedentary lifestyle and unhealthy food consumption
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patterns, including higher daily intake of calories and cholesterol, are common among individuals with major psychotic and/or affective disorders [11,14].
Previous interventions tested

Many interventions intended to decrease risk factors for
metabolic syndrome, both pharmacological and nonpharmacological, have been tested and described in the
literature. Systematic reviews and meta-analyses of interventions to control risk factors for metabolic syndrome
[15-23] indicate that both pharmacological and nonpharmacological (that is, behavioral or educational) interventions can be effective in decreasing metabolic risk. The
studies described in these systematic reviews generally
take place in mental health settings, which may exclude
those individuals with mental illness who receive treatment primarily in the primary care setting. Only one study
included in these reviews [24] features a primary carebased intervention. Previous weight loss interventions
conducted in the primary care setting have demonstrated
efficacy in many populations [25-29].
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This review focuses on non-pharmacological, educationbased interventions to address metabolic syndrome risk
factors in patients with major psychotic or affective/
mood disorders who are treated in the primary care setting. The emphasis is on metabolic syndrome risk factors because this combination of risk factors can lead to
chronic illnesses and early mortality in this population
[35]. Education-based interventions are important because they empower the patient to manage his/her illness
independently and expand the role of social workers in
the primary care setting. According to Michie, Fixsen,
Grimshaw and Eccles [36], systematic reviews of behavior
change interventions typically produce modest effects.
The primary author was involved in a primary care-based
complex intervention to improve metabolic risk factors
among patients with major psychotic and/or affective/
mood disorders and patient reports indicated that they
found the educational components most beneficial for
self-management of illnesses [37].

Methods
Literature search

Mental illness in primary care

Individuals with major psychotic or affective/mood disorders who are not psychiatrically hospitalized are generally
treated for physical and sometimes mental health disorders in primary care settings in the U.S. due to a lack of
integrated medical and behavioral health programs. Several studies in the U.S. and elsewhere have noted the
prevalence of major psychotic or affective/mood disorders
in the primary care setting. Serrano-Blanco et al. [30] conducted a study with over 3,800 primary care patients and
found that 29.9% had a diagnosis of major depressive disorder. Das et al. [31] screened 1,157 primary care patients
and found that approximately 10% met diagnostic criteria
for bipolar disorder. Blount [32] reported that 80% of individuals with a mental health disorder will see their primary
care physician in a given year, while only 50% will see a
mental health provider. Roca et al. [33] reported on a
similar study of more than 7,900 primary care patients
and found that 29% of patients had been diagnosed with
major depressive disorder. Fernandez et al. [34] conducted
a cross-sectional study in primary care and found that
mood disorders are the second leading cause of qualityadjusted life years in the primary care setting. The loss of
quality of life and prevalence of psychiatric disorders in
primary care demonstrates a need for primary-care based
interventions to decrease chronic comorbid conditions.
Objectives of review

The prevalence of psychiatric disorders in primary care settings and the association between chronic mental and
physical illness necessitates an exploration of primary carebased interventions to address these comorbid conditions.

Electronic searches were conducted using MEDLINE, PsychINFO and the trials registry of the Cochrane Database
of Systematic Reviews. The abstracts, titles and index
terms of studies were searched in MEDLINE and PsychINFO using the following keywords: “schizophreni*” OR
“schizoaffective” OR “bipolar” OR “major depressive disorder” OR “posttraumatic stress disorder” OR “serious
mental illness” AND “metabolic syndrome” OR “high
blood pressure” OR “triglycerides” OR “cholesterol” OR
“HDL” OR “waist circumference” OR “blood sugar” OR
“blood glucose” AND “intervention” OR “randomized
controlled trial” OR “quasi-randomized” AND “primary
care.” All titles in the Cochrane Schizophrenia Register
were scanned for possible inclusion. Additionally, manual
searches were conducted using references from literature
found in the database search.
Eligibility assessment
Inclusion and exclusion criteria

Studies were included if the population studied met the
following criteria: adults ages 18 or older; diagnosed with
one of the five mental illnesses which typically constitute
major psychotic and/or affective disorders (schizophrenia (DSM-V code 295.9), schizoaffective disorder (DSMV code 295.7), major depressive disorder (DSM-V code
296.3), or bipolar disorder (DSM-V codes 296.4 and
296.5)); and had risk factors for metabolic syndrome, including large waistline, a high triglyceride level, a low
HDL cholesterol level, high blood pressure, and high
fasting blood sugar level. The study setting must have
been in a primary care location. The study design must
have been either a randomized controlled trial (RCT) or
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a quasi-experimental study. Study outcomes must include one of the risk factors for metabolic syndrome (for
example, blood pressure, waist circumference, triglyceride levels, blood glucose or (an increase in) HDL).
Studies were excluded if:
 the population studied was younger than 18 years

old or did not have a diagnosis of a major psychotic
and/or affective disorders or risk factors for
metabolic syndrome;
 they were conducted in an inpatient or mental
health-based setting;
 they were not an RCT or quasi-experimental study,
and
 the outcome of the study did not include one of the
risk factors for metabolic syndrome.

Results
Our initial systematic search of databases MEDLINE
and PsychINFO (which was not limited by setting)
yielded 316 results. When "primary care" was added to
the search, we found 19 additional results. A title search
of the Cochrane Database of Systematic Reviews resulted
in the identification of two systematic reviews; one review had no included studies and the other had six studies included in the quantitative synthesis. These studies
were also identified in database searches and are part of
the 363 total studies identified below. Manual searches
from reference lists of articles found in the database
search were conducted and 90 studies were found. A
search of gray literature was conducted to decrease risk
of publication bias using Open Grey (www.opengrey.eu)
with the same MESH terms, but no additional studies
were found. A total of 363 unique studies were found
from the collection of searches after duplicates were
removed. The titles of all 363 of these results were
reviewed separately by each reviewer and 303 were excluded based on setting or nature of intervention. There
were no disagreements during this process. The remaining 60 articles were reviewed in abstract and 30
were excluded based on study design or setting. Full-text
reviews were conducted by both reviewers CN and SJ
for the remaining 30 of the studies and reviewers agreed
that no studies met inclusion criteria; all studies were
excluded. Additional file 1 provides a diagram of how
studies were excluded. Table 1 lists all of the studies
reviewed in full-text from database searches and manual
searches with reasons for exclusion.
Through the manual search, 13 systematic reviews
were identified for further review of citations. Table 2
provides a list of the 13 systematic reviews. These reviews examined a total of 221 studies. Raters CN and SJ
independently screened titles or abstracts from these
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studies and all 221 studies were rejected for not meeting
the inclusion criteria.

Discussion
Although we identified no studies that met the a priori
inclusion criteria, there were 16 studies identified during
database and manual searches that examined similar interventions in non-primary care settings. These studies
(listed in Table 3) demonstrate that controlled trials with
education interventions to improve physical health can
be conducted with individuals with major psychotic and/
or affective disorders; the systematic reviews shown in
Table 2 indicate that these interventions can be effective.
Also, it should be recognized that no evidence of effective primary care-based studies does not mean that such
intervention is ineffective; further studies are needed in
this area to determine whether such interventions can
be effective in primary care settings.
Of the 16 similar studies of educational interventions,
reviewers identified 6 studies that may be able to be implemented in the primary care setting [42,51,53,56,63,65].
Those studies of interventions that might not be appropriate for primary care include interventions that were too
long [45,47,61], provided products or services that might
not be available in primary care settings [43,48,55,62,71]
or required patients to have not yet developed physical
risk factors prior to the intervention [46].
An examination and discussion of the details of the
interventional components of the studies possible in
primary care identified in Table 3 is warranted here,
because future studies in the primary care setting must
adequately describe their interventions in order to be
replicated or subject to systematic review. The methodological quality of these studies is summarized in Table 4.
All of these studies provided explicit descriptions of the
intervention components; McKibbin et al. [56], Weber
and Wyne [65] and Kwon et al. [53] also described
session-by-session content of the intervention in table
and narrative format; Brar et al. [42] described sessions
in narrative format only. Khazaal et al. [51] used an
intervention previously developed by one of the authors,
so readers can review that intervention in detail elsewhere, but it was not described in detail in the article.
Srkinar et al. [63] provided a description of the length of
the educational intervention and a list of topics, but no
sequence or table of sessions was provided. All studies
identified as possible in primary care included an intervention element that was not education (or example,
food tasting, exercise sessions, provision of pedometers),
so the effectiveness of the educational component alone
may not be able to be determined from these studies;
however, complex interventions are very common in behavioral health research [72].
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Table 1 Studies reviewed in full-text
Authors, year

Reason for exclusion

Alvarez-Jiminez et al., [38]

Partially pharmacological intervention, mix of different settings (including primary care).

Attux, Martini, de Araujo, Roma, Reis and Bressan, [39]

Not RCT; not primary care (mental health services)

Ball, Coons and Buchanan, [40]

Not primary care (both arms from outpatient MH services); not randomized

Bradshaw, Lovell and Harris, [41]

Not an RCT, not primary care

Brar et al., [42]

Not primary care

Brown, Goetz, Van Sciver, Sullivan and Hamera, [43]

Not primary care

Centorrino et al., [44]

Not primary care; no control group

Chafetz, White, Collins-Bride, Cooper and Nickens, [45]

Not primary care

Druss, Rohrbaugh, Levinson and Rosenheck, [24]

Wrong outcome

Evans, Newton and Higgins, [46]

Not primary care

Fosberg, Bjorkman, Sandman and Sandlund, [47]

Not primary care

Jean-Baptiste et al., [48]

Not primary care

Jones, Basson, Walker, Crawford and Kinon, [49]

Pharmacological intervention

Kalarchian et al., [50]

Not an RCT, not primary care

Khazaal et al., [51]

Not primary care

Kilbourne et al., [52]

Not primary care; outcome not physical health

Kwon et al., [53]

Not primary care

Littrell, Hilligoss, Kirshner, Petty and Johnson, [54]

Not primary care, partially pharmacological

Mauri et al., [55]

Not primary care

McKibbin et al., [56]

Not primary care

Ohlson, Treasure and Pilowsky, [57]

Not RCT; not primary care

Park, Usher and Foster, [58]

Review paper

Pendlebury, Bushe, Wildgust and Holt, [59]

Not primary care, no control group

Perlman et al., [60]

Not RCT; not primary care

Poulin et al., [61]

Not primary care

Rotatori, Fox and Wicks, [62]

Not primary care

Skrinar, Huxley, Hutchinson, Menninger and Glew, [63]

Not primary care

Vreeland et al., [64]

Not primary care, not randomized

Weber and Wyne, [65]

Not primary care

Weber and Nelson, [66]

Not RCT; not primary care

Missing from the descriptions of many articles reviewed
in this study were details about who implemented an
intervention and where it took place. A number of studies
stated that participants were recruited from a certain
hospital or facility (for example, Khazaal et al. [51] and
Skrinar et al. [63], but it was not clear from the articles
whether the actual educational intervention took place in
the hospital or in an outpatient setting. Of the studies
identified as possible in primary care, only Khazaal et al.
[51], Kwon et al. [53] and Weber and Wyne [65] provided
a clear description of who was implementing the intervention, so it is not clear if academic researchers, dietitians,
medical professionals or social workers were implementing the other interventions. It is also not clear in several
studies, including Srkinar et al. [63] and Khazaal et al.
[51], who was collecting any of the data, which could

affect participant outcomes (for example, if the patients
had an existing relationship with the data collectors) and
may be subject to detection bias if assessors were not blind
to allocation.
Health outcomes from complex behavioral interventions can be nebulous because multiple factors affect
outcomes; however, the RCT format of the studies discussed here improves study rigor [73]. Two studies
[63,65] resulted in no statistically significant reduction
in metabolic risk factors, with both studies citing small
sample sizes and other factors (for example, lack of
transportation, motivation) as being possible explanations for these results. Khazaal et al. [51] found limited
reduction in weight and body mass index (BMI) in the
experimental group. Some subjects’ medications were
also changed during the study, although the authors
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Table 2 Systematic reviews
Authors, year

Title

# of studies
reviewed in
article

Conclusions

Alvarez-Jiminez,
Non-pharmacological management of antipsychoticHetrick, Gonzalez-Blanch, induced weight gain: systematic review and
Gleeson and McGorry, [15] meta-analysis of randomized controlled trials

10

Individual and group interventions, cognitive
behavioral therapy and nutritional counseling were
more effective than treatment as usual.

Bradshaw, Lovell and
Harris, [16]

Healthy living interventions and schizophrenia: a
systematic review

16

Inconclusive based on poor quality of studies
reviewed.

Cabassa, Ezell and LewisFernandez, [67]

Lifestyle interventions for adults with serious
mental illness: a systematic literature review

23

Behavioral interventions generally showed
improvement in metabolic syndrome risk factors

Caemmerer, Correll and
Maayan, [68]

Acute and maintenance effects of non-pharmacological
interventions for antipsychotic induced weight gain and
metabolic abnormalities: a meta-analytic comparison of
randomized controlled trials

18

Behavioral interventions effectively prevented and
reduced weight gain in outpatients agreeing to
participate in trials. Nutritional and cognitive
behavioral interventions were effective.

Cimo,Stergiopoulis,
Cheng, Bonato and
Dewa, [69]

Effective lifestyle interventions to improve type 2
diabetes self-management

4

Diabetes education is effective when it includes
diet and exercise and design should address
cognition, motivation and weight gain

Faulkner, Soundy and
Lloyd, [17]

Schizophrenia and weight management: a
systematic review of interventions to control
weight

16

All behavioral interventions produced small
reductions in, or maintenance of, weight.

Gabriele, Dubert and
Reeves, [18]

Efficacy of behavioural interventions in managing
atypical antipsychotic weight gain

16

When behavioral interventions were initiated at
the start of atypical antipsychotic (AAP) treatment,
amount of weight gain was decreased. When
initiated after the start of AAP treatment, weight
loss was achieved. Insulin regulation and A1c
(metabolic syndrome risk factors) were also
improved.

Megna, Schwartz, Siddiqui Obesity in adults with serious and persistent
and Rojas, [19]
mental illness: a review of postulated mechanisms
and current interventions

71

Non-pharmacological interventions are promising,
but only show low to medium effect size.

Papanastasiou, [20]

Interventions for the metabolic syndrome in
schizophrenia: a review

15

Behavioral interventions showed benefit, but study
design (non-RCT) did not prove one intervention
superior to another.

Roberts and Bailey, [21]

Incentives and barriers to lifestyle interventions for
people with severe mental illness: a narrative
synthesis of quantitative, qualitative and mixed
methods studies

14

No studies identified that specifically focus on
incentives and barriers

Tosh. Clifton, Mala and
Bachner, [70]

Physical health care monitoring for people with
serious mental illness

0

No studies identified that specifically focus on
incentives and barriers.

Tosh, Clifton and
Bachner, [22]

General physical health advice for people with
serious mental illness

6

Health advice could lead to greater access of
services but ineffective advice may be a waste of
resources.

Werneke, Taylor, Sanders
and Wessely, [23]

Behavioral management of antipsychotic-induced
weight gain: a review

12

No RCTs identified, but interventions appear to be
effective.

Total

221

used statistical methods to account for the possible impact of these changes [51]. McKibbin et al. [56] and
Kwon et al. [53] reported significant reductions in
metabolic syndrome risk factors (weight, BMI) as a result of their interventions. Kwon et al. [53] also observed significant weight loss in the control group,
which suggests possible threats to internal validity in
the design. These authors do note that several members
of the experimental group lost a greater percentage of
body weight than anyone in the control group.

Conclusions
The authors were unable to identify rigorous, primary
care-based interventions to address physical illness among
individuals with mental illness. As the literature expands
to include primary care-based interventions, additional
systematic reviews and meta-analyses are warranted to assess effectiveness in this setting. Systematic reviews of
high-quality RCTs are the most rigorous form of effectiveness research, as single RCTs can have weak designs or
biased results [73]. Quality assurance protocols, such as

Authors, year

Title

Setting

Description of intervention

Brar et al., [42]
Brown, Goetz, Van Sciver,
Sullivan and Hamera, [43]

Effects of behavioral therapy on weight loss in overweight and
obese patients with schizophrenia or schizoaffective disorder

Mental health

Manual-based behavioral techniques for weight loss

14 weeks

Yes

A psychiatric rehabilitation approach to weight loss

Mental health

Goal setting, social support, skills training, more
frequent visits with providers, meal replacements

12 weeks

No

Short term
residential
treatment

Promoting individual skills in self-management of
illness

12 months

No

Chafetz, White, Collins-Bride, Clinical trial of wellness training: health promotion for severely
Cooper and Nickens, [45]
mentally ill adults

Length of Appropriate
intervention for primary
care

Nutritional intervention to prevent weight gain in patients
commenced on olanzapine: a randomized controlled trial

Mental health

Nutrition education sessions

12 weeks

No

Fosberg, Bjorkman,
Sandman and
Sandlund, [47]

Physical health – a cluster randomized controlled lifestyle
intervention among persons with a psychiatric disability and their
staff

Residential
mental health

Curriculum including motivation, food content, stress
and fitness

12 months

No

Jean-Baptiste et al., [48]

A pilot study of a weight management program with food
provision in schizophrenia

Mental health

Weekly group sessions w/dietitian and psychiatrist,
pedometers and food (or reimbursement) provided,
individual nutrition support, grocery store visit

16 weeks

No

Khazaal et al., [51]

Cognitive behavioral therapy for weight gain associated with
antipsychotic drugs

Mental health

Cognitive behavioral therapy

12 weeks

Yes

Kilbourne et al., [52]

Improving medical and psychiatric outcomes among individuals
with bipolar disorder: a randomized controlled trial

Mental health

Self-management sessions on bipolar disorder,
promotion of provider engagement, education
related to cardiovascular disease

4 weeks

Yes

Kwon et al., [53]

Weight management program for treatment-emergent weight
gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled trial

Mental health

Educational program with food diary, nutrition
education, exercise management

12 weeks

Yes

Mauri et al., [55]

A psychoeducational program for weight loss in patients who
have experienced weight gain during antipsychotic treatment
with olanzapine

Mental health

Weekly psycho-educational meetings emphasizing
weight loss with personalized diet plans

24 weeks

No

McKibbin et al., [56]

A lifestyle intervention for older schizophrenia patients with
diabetes mellitus: a randomized controlled trial

Residential
mental health

Diabetes Awareness and Rehabilitation Training
(DART)

24 weeks

Yes

Mcreadie et al., [71]

Dietary improvement in ppl with schizophrenia: randomized
controlled trial

Residential
mental health

Giving fruit, veggies and meal planning to patients
(vs. fruit/vegetables alone)

6 months

No

Poulin et al., 2007 [61]

Management of antipsychotic induced weight gain: prospective
naturalistic study of the effectiveness of a supervised exercise
programme

Mental health

Education, physical education counseling and
exercise

18 months

No

Rotatori, Fox and Wicks, [62] Weight loss with psychiatric residents in a behavioral self-control
program

Inpatient
mental health

Behavior therapy

14 weeks

No

Skrinar, Huxley, Hutchinson,
Menninger and Glew, [63]

The role of a fitness intervention on people with serious
psychiatric disabilities

Mental health

Exercise, weekly education seminars

12 weeks

Yes

Weber and Wyne, [65]

A cognitive behavioral group intervention for weight loss in
patients treated with atypical antipsychotics

Mental health

Based on Diabetes Prevention Project (DPP) program
to prevent diabetes

16 weeks

Yes
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Evans, Newton and
Higgins, [46]
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Table 3 Similar interventions not in primary care settings

Author, date

Type of Sample
study
size

Power
How
analysis
participant
described characteristics
described

Review
Randomization
board
process
approved described

Comparator

Blinding Evidence base for
described intervention
described

Statistical analysis
described

Brar et al., [42]

RCT

71

Yes

Narrative

Yes

No

Monthly weight checks
and encouragement of
weight loss

No

Yes; table with
previous studies

Yes (paired t-tests, logistic
regression, ANCOVA,
Cochran-mantel-Haenszel)

Khazaal et al., [51]

RCT

61

No

Table

Yes

No

Control group with brief
nutritional education

No

Yes; previous "Apple
Pie" study

Yes (t-tests, Chi-square,
MANOVA, MANCOVA,
Fisher's exact significance
tests, Cochran's Q test)

Kwon et al., [53]

RCT

48

Yes

Table

Yes

No

Routine care with verbal
No
diet and weight management
recommendations. Control
group also given food and
exercise diaries.

No

Yes (t-test and ANCOVA)

McKibbin et al., [56] RCT

64

No

Table

Yes

No

Usual care with three healthrelated brochures distributed

No

Yes; previous DART
study and theoretical
orientation

Yes (ANOVA, t-tests, chisquare)

Skrinar, Huxley,
Hutchison,
Menninger and
Glew, [63]

RCT

20

No

Table

Yes

No

Waiting list control group

No

Yes; cites literature
about role of exercise
in weight
management

Yes (ANOVA)

Weber and
Wyne, [65]

RCT

17

No (pilot
study)

Table

Yes

No

Control group received
treatment as usual and
were weighed every four
weeks.

Yes

Yes; previous Diabetes
Prevention Project

Yes (t-testt-test, statistical
significance set at 0.05)
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Table 4 Methodological quality of studies appropriate for primary care
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the CLEAR NPT checklist for non-pharmacological trials
[74], which provides a checklist for components of quality
in a study, should be incorporated into future studies in
this area to provide standardized guidelines for making
effectiveness claims.
Adequate reporting of interventional content and components is also essential to the expansion of literature in
this subject area and groups, such as the Workgroup
for Intervention Development and Evaluation Research
(WIDER), have developed suggestions for intervention
reporting (http://interventiondesign.co.uk). WIDER advocates for the successful adoption of behavior change interventions and the expansion of CONSORT (www.consortstatement.org) and APA guidelines to allow for improved
reporting of these interventions. In behavioral intervention
research, theories regarding the specific mechanism of
change within an intervention should be utilized during
the development of the intervention and should be described in the final report [36].
Social work researchers and direct service social
workers in health care settings have an opportunity to
design and implement high-quality behavioral and educational programs for individuals with major psychotic
and/or affective disorders using the criteria described
above. Social workers are among the few professionals in
health care settings who have the skills and opportunity
to work closely with the patients most in need of healthrelated behavior change interventions, as they are generally able to spend more time with patients in health care
settings and have access to medical information in collocated health and mental health settings. Interventions to
decrease metabolic syndrome risk factors have been
demonstrated to be successful in mental health settings,
but the primary service in mental health settings is mental health. Primary care-based interventions are important for conveying the message that the focus is on
physical health, even if the population is comprised of
individuals with major psychotic and/or affective disorders. Social workers or social work researchers participating in health-focused interventions that do not follow
published guidelines for research and reporting of RCTs
are missing an important opportunity to enhance systematic reviews of literature about this population.

Additional file
Additional file 1: PRISMA diagram for BMC. PRISMA 2009 Flow
Diagram. PRISMA diagram of studies excluded.

Abbreviations
AAP: Atypical antipsychotic medication; BMI: Body mass index;
DART: Diabetes Awareness and Rehabilitation Training; RCT: Randomized
control trial.
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